In the mosquito–human life cycle, the six species of malaria parasites infecting humans
(Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale wallickeri, Plasmodium …

Coevolution of humans and malaria parasites has generated an intricate balance between
the immune system of the host and virulence factors of the parasite, equilibrating maximal …

Protective antibodies in Plasmodium falciparum malaria are only acquired after years of
repeated infections. Chronic malaria exposure is associated with a large increase in atypical …

With increasing malaria control and goals of malaria elimination, many endemic areas are
transitioning from high-to-low-to-no malaria transmission. Reductions in transmission will …

Plasmodium falciparum malaria still remains a major global public health challenge with
over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur …

Background Antibodies against merozoite antigens are key components of malaria
immunity. The naturally acquired antibody response to these antigens is generally …

Following the 2008 global financial crisis, small-scale gold mining operations proliferated
worldwide. Along Ghana's Offin River, the landscape has been radically transformed by …

Evidence accumulated through the years clearly indicates that antiparasite immune
responses can efficiently control malaria parasite infection at all development stages, and …

Malaria is a widespread disease caused mainly by the Plasmodium falciparum (Pf) and
Plasmodium vivax (Pv) protozoan parasites. Depending on the parasite responsible for the …

Background: Monitoring malaria transmission is a critical component of efforts to achieve
targets for elimination and eradication. Two commonly monitored metrics of transmission …